J&J, Janssen Face Risperdal Suit From Cherokee Nation
Johnson & Johnson Inc. and subsidiary Janssen Pharmaceuticals Inc. removed a suit to Oklahoma federal court in which the Cherokee Nation claims that the companies misbranded its anti-psychotic Risperdal and failed...To view the full article, register now.
Already a subscriber? Click here to view full article